A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2011
08/03/2011	EP2349247A1 Chewing gum containing low dose amounts of water soluble vitamins
08/03/2011	EP2349246A1 Choline salts of succinic acid for the treatment of depression, anxiety, schizophrenia, sleep disorder, and epilepsy
08/03/2011	EP2349245A2 Treatment of retroviral reservoirs exploiting oxidative stress
08/03/2011	EP2349243A1 Urea-based film-forming solution for treating nail psoriasis
08/03/2011	EP2349242A2 Amino acid salts of prostaglandins
08/03/2011	EP2349241A1 Pharmaceutical compositions with attenuated release of phenolic opioids
08/03/2011	EP2349240A1 Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral or non-oral antidiabetic drug
08/03/2011	EP2349239A1 Detection and use of low molecular-weight modulators of the cold-menthol receptor trpm8
08/03/2011	EP2349238A1 Co-crystals of tramadol and nsaids
08/03/2011	EP2349237A2 Curcumin nanoparticles and methods of producing the same
08/03/2011	EP2349236A2 Compositions and methods for treating or preventing hypoxic or ischemic injury
08/03/2011	EP2349235A1 Use of catecholic butane derivatives in cancer therapy
08/03/2011	EP2349234A1 New formulations with anti-neoplastic activity
08/03/2011	EP2349233A1 Use of scyllo-inositols for the treatment of macular degeneration-related disorders
08/03/2011	EP2349232A1 Ophthalmic compositions useful for improving visual acuity
08/03/2011	EP2349231A1 Compositions and methods for treating hoof diseases
08/03/2011	EP2349230A2 Amorphous rotigotine transdermal system
08/03/2011	EP2349229A1 Improved nanoparticulate compositions of poorly soluble compounds
08/03/2011	EP2349226A1 Novel method for preparing granulates of active principles, and granulates obtained thereof
08/03/2011	EP2349223A2 Dosage units of 3-(6-(1-(2,2-difluorobenzo [d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid
08/03/2011	EP2349221A2 Sustained release drug delivery system
08/03/2011	EP2349220A1 Using of organic solvents in wet granulation of moxifloxacin
08/03/2011	EP2349217A1 Novel composition based on gamma-hydroxybutyric acid
08/03/2011	EP2349216A2 Mouthwash in the form of a stable suspension comprising microspheres that incorporate an active ingredient
08/03/2011	EP2349215A1 Tablet containing valsartan
08/03/2011	EP2349211A2 Formulations comprising ezetimibe
08/03/2011	EP2349208A1 Intravaginal delivery system and process for manufacturing it
08/03/2011	EP2349207A1 Liquid pharmaceutical formulation containing paracetamol
08/03/2011	EP2349206A2 Corticosteroid compositions and methods of treatments thereof
08/03/2011	EP2349205A2 Chewable gelled emulsions
08/03/2011	EP2349203A2 Heat sterilised injectable composition of hyaluronic acid or one of the salts thereof, polyols and lidocaine
08/03/2011	EP2349188A1 Aqueous saline solutions for the destruction of fatty tissue
08/03/2011	EP2348885A1 Biscuit comprising guar gum
08/03/2011	EP2348868A1 Novel mitochondrial uncoupling methods and compositions for enhancing adipocyte thermogenesis
08/03/2011	EP2348864A2 Oxidized thiophospholipid compounds and uses thereof
08/03/2011	EP2348863A1 Boron-containing small molecules
08/03/2011	EP2348860A1 Pyrazolopyrimidine jak inhibitor compounds and methods
08/03/2011	EP2348859A1 Prodrugs of oxazolidinone cetp inhibitors
08/03/2011	EP2348858A1 Method of treating thrombocytopenia
08/03/2011	EP2348857A1 Novel cyclic benzimidazole derivatives useful anti-diabetic agents
08/03/2011	EP2348855A2 Small molecule compounds for stem cell differentiation
08/03/2011	EP2348854A2 Methods and compositions for treating bacterial infections by inhibiting quorum sensing
08/03/2011	EP2348848A1 Treatment of hepatitis c infection with metalloporphyrins
08/03/2011	EP2348847A1 Azepino [4, 5-b] indoles and methods of use
08/03/2011	EP2348846A1 Disubstituted azepan orexin receptor antagonists
08/03/2011	EP2348845A1 Ansamycin hydroquinone compositions
08/03/2011	EP2348844A1 Cross- linked fatty acid-based biomaterials
08/03/2011	EP2348843A1 Selective proton coupled folate transporter and folate receptor, and garftase inhibitor compounds and methods of using the same
08/03/2011	EP2348839A1 Lysosomotropic inhibitors of acid ceramidase
08/03/2011	EP2348832A1 Preservative system for emulsion-based therapeutic topical formulations
08/03/2011	EP2240458B1 Aryl sulfonamides as effective analgesics
08/03/2011	EP2234607B1 A slow-release formulation based on an association of glycogen and alginate
08/03/2011	EP2231121B1 Pharmaceutical compositions
08/03/2011	EP2222293B1 Medical use of 3-(2,2,2-trimethylhydrazinium) propionate hydrogen fumarate and dihydrogen phosphate
08/03/2011	EP2220059B1 2-aminooxazole derivatives as trpvl antagonists useful for treating pain
08/03/2011	EP2200980B1 Amino arylsulfonamide compounds and their use as 5-ht6 ligands field of invention
08/03/2011	EP2183222B1 Azoloraine derivatives, method for the production thereof, pharmaceuticals containing these compounds, and the use thereof
08/03/2011	EP2155690B1 Indazolamide derivatives
08/03/2011	EP2152674B1 Benzimidazolone chymase inhibitors
08/03/2011	EP2132185B1 Pyrimidinyl-piperazines useful as dopamine d3/d2 receptor ligands
08/03/2011	EP2125807B1 Imidazo[1,2-a]pyrrolo[3,2-c]pyridine compounds useful as pestivirus inhibitors
08/03/2011	EP2125782B1 Aryl carboxylic acid cyclohexyl amide derivatives
08/03/2011	EP2117552B1 Use of condensed pyrimidine derivatives for the treatment of autoimmune and inflammatory diseases
08/03/2011	EP2114970B1 Tricyclic compounds and their use as glucocorticoid receptor modulators
08/03/2011	EP2004168B1 Stable oral pharmaceutical composition containing thyroid hormone receptor agonists
08/03/2011	EP1996542B1 Aliskiren nitrate salt
08/03/2011	EP1996180B1 Benzamide and pyridylamide derivatives as antibacterial agents
08/03/2011	EP1976502B1 Small molecule inhibitors of pdz interactions
08/03/2011	EP1963295B1 3, 6-dihydro-2-oxo-6h-(1,3,4)thiadiazine derivatives
08/03/2011	EP1948638B1 Compounds for the treatment of inflammatory disorders
08/03/2011	EP1934198B1 Polymorphs of benzoate salt of 2-[[6-[(3r)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2h)-pyrimidinyl]methyl]-benzonitrile and methods of use therefor
08/03/2011	EP1893612B1 Pyrrolo [2, 3-b]pyridine derivatives as protein kinase inhibitors
08/03/2011	EP1893207B1 Use of substituted piperazine derivatives and morpholine derivatives
08/03/2011	EP1878429B1 Trenadermal absorption preparation
08/03/2011	EP1853587B1 Novel heterocyclic substituted pyridine or phenyl compounds with cxcr3 antagonist activity
08/03/2011	EP1846366B1 Norvaline derivative and method for preparation thereof
08/03/2011	EP1836172B1 5-ht7 receptor antagonists
08/03/2011	EP1833791B1 2,3,4,9-tetrahydro-1h-carbazole derivatives as crth2 receptor antagonists
08/03/2011	EP1819683B1 Potassium salt of an hiv integrase inhibitor
08/03/2011	EP1809268B1 Alpha-humulene for use in the prophylaxis or treatment of inflammatory pain or oedema
08/03/2011	EP1809241B1 Dye-free pharmaceutical suspensions comprising acetaminophen
08/03/2011	EP1802633B1 Benzothieno[2,3-d]pyrimidine compounds as inhibitors of tyrosine kinase activities of the epidermal growth factor receptors (egfrs) for the treatment of hyperproliferative diseases
08/03/2011	EP1794146B1 Tricyclic anilide spirohydantoin cgrp receptor antagonists
08/03/2011	EP1786905B1 Small interfering rna molecules against ribonucleotide reductase and uses thereof
08/03/2011	EP1758586B1 Composition in spray form comprising a combination of a corticoid and a vitamin d derivative in an oily phase
08/03/2011	EP1748780B1 Methods and related compositions for reduction of fat
08/03/2011	EP1697326B1 Crystal form of quinoline compound and process for its production
08/03/2011	EP1688432B1 Igm high concentration stabilized solution
08/03/2011	EP1675572B1 Coated metal pyrithione particles for treatment of microorganisms
08/03/2011	EP1633722B1 Preparation and use of aryl alkyl acid derivatives for the treatment of obesity
08/03/2011	EP1490368B1 2,2-bis(hydroxymethyl)cyclopropylidenemethyl - purines and -pyrimidines as antiviral agents
08/03/2011	EP1480634B1 Selective androgen receptor modulators (SARMs) for treating benign prostate hyperplasia
08/03/2011	EP1446104B2 Spray drying methods
08/03/2011	EP1425272B1 Optical isomers of an iloperidone metabolite
08/03/2011	EP1409022B1 Pharmaceutical mousse composition comprising salicylic acid
08/03/2011	EP1391202B1 Liquid drug preparations
08/03/2011	EP1212055B1 Neurotherapeutic composition comprising a beta-lactam compound
08/03/2011	EP1078092B1 Expression vectors for stimulating an immune response and methods of using the same
08/03/2011	EP1047413B1 Pharmaceutical composition comprising a specific inhibitor of aminopeptidase a, in particular ec33, for decreasing blood pressure
08/03/2011	CN201912478U 特福猛片剂及其包衣 Tefal fierce and coated tablets

1 ... 1623 1624 1625 1626 1627 1628 1629 1630 1631 1632 1633 1634 1635 1636 1637 1638 1639 1640 1641 1642 1643 ... 7860